Short answer
Atea Pharmaceuticals, Inc. (AVIR) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 74.65% of outstanding shares represented at June 18 annual meeting, providing strong shareholder participation.
Atea Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 74.65% of outstanding shares represented at June 18 annual meeting, providing strong shareholder participation
- Jerome Adams, Howard Berman and Barbara Duncan elected Class III directors through 2029
- Adams received 28,798,012 votes for versus 22,275,665 withheld, signaling comparatively weak shareholder support
- KPMG appointment ratified with 58,894,207 votes for and 783,081 against
- Executive compensation approved non-bindingly with 47,452,759 votes for and 2,977,290 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Atea Pharmaceuticals, Inc. 8-K filings
Get the next AVIR 8-K as it lands
Follow AVIR for push alerts, or ask the research agent what this filing means.